Astrazeneca Company Timeline (AZN)

REFILE-FDA drug center head expected to leave after commissioner's exit, sources say

* Hoeg's departure comes amid broader shakeup of ​health agency

CORRECT: AstraZeneca bladder cancer trial yields encouraging results

(Correction clarifies that the phase III Volga trial was conducted across three arms and provides the findings for arms 1 and 2 versus the comparator arm)

AstraZeneca immunotherapy for stomach cancer green lit for NHS use

(Alliance News) - Patients with aggressive stomach cancer are to benefit from a new type of treatment after the NHS spending watchdog approved the first immunotherapy for people with this form of canc...

AstraZeneca reports positive results from bladder cancer drug trial

(Sharecast News) - UK pharma group AstraZeneca on Thursday reported positive results from the Phase III VOLGA trial for its Imfinzi bladder cancer treatment.

AstraZeneca's bladder cancer drug yields encouraging test results

(Alliance News) - AstraZeneca PLC on Thursday posted positive trial results for its bladder cancer treatment imfinzi.

AstraZeneca hails phase-3 trial results for hypoparathyroidism drug

(Alliance News) - AstraZeneca on Tuesday hailed encouraging test results for its hypoparathyroidism drug eneboparatide.

Novo Nordisk weight-loss pill powers profit beat in race to catch Eli Lilly

* Novo nudges up full-year guidance ​after sales, profit beats

LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities

(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday:

UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh

May 1 (Reuters) - London's blue-chip FTSE 100 closed slightly lower on ​Friday, ‌dragged down by losses in heavyweight energy stocks and drugmaker AstraZeneca, while a looming UK public ⁠holiday thinn...

LONDON MARKET CLOSE: Oil price declines amid reports of new Iran offer

(Alliance News) - The FTSE 100 closed down on Friday, but above early lows, while the oil price fell amid reports that Iran has made a new proposal amid stalled US peace talks.

London close: Stocks mixed as investors mull longer Hormuz blockade

(Sharecast News) - London stocks ended mixed on Friday as investors weighed ongoing concerns about the Strait of Hormuz blockade against resilient domestic data, after the Bank of England warned that...

AstraZeneca shares dip after US regulatory panel rejects breast cancer drug

* FDA panel votes against camizestrant over trial design concerns

Mixed outcome for AstraZeneca as US committee votes on cancer drugs

(Alliance News) - AstraZeneca PLC on Friday said it had secured a recommendation for its cancer drug Truqap from US authorities, but failed to secure a majority in favour of its treatment camizestrant...

IN BRIEF: AstraZeneca gets FDA panel nod for Truqap in prostate cancer

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Says the US Food & Drug Administration's Oncologic Drugs Advisory Committee recommended the benefit–risk profile of Truqap when used w...

European shares log biggest monthly gains in over a year

* Defense stocks ​lead gains, aided by Rolls-Royce

LONDON BROKER RATINGS: UBS, Goldman and Citi say 'buy' Lloyds Banking

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

European shares hit three-week low as earnings, data and Iran conflict weigh

* Earnings mixed. Healthcare stocks drag, Adidas outperforming

LONDON MARKET CLOSE: Stocks wilt as oil soars ahead of likely Fed hold

(Alliance News) - The FTSE 100 closed lower on Wednesday, held back by falls in drugs firms GSK and AstraZeneca, while oil surged amid reports that the US is eyeing a longer blockade of the Strait of...

GSK shares slide as investors question one-off result boost

* Stock top ⁠decliner on the FTSE 100

AstraZeneca tops profit estimates, warns US drug pricing could hit launches elsewhere

* Q1 oncology sales up 16%, rare disease sales up 15%

AstraZeneca to invest $405 million in Britain after US-UK pharma deal

* Investment follows US-UK deal aimed at increased ​drug prices

AstraZeneca to pump GBP300 million into UK - PM Keir Starmer

(Alliance News) - Cambridge, England-based pharmaceutical firm AstraZeneca PLC will pump GBP300 million into UK drugs development in a "major vote of confidence" in the country, the prime minister has...

WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

LONDON MARKET OPEN: Stocks slide as pharma drags FTSE 100 down

(Alliance News) - Stock prices in London opened lower on Wednesday, as renewed uncertainty in energy markets and a heavy slate of corporate updates weighed on sentiment ahead of the Fed's rate call.

AstraZeneca backs outlook as first quarter sales and profit beat hopes

(Alliance News) - AstraZeneca PLC on Wednesday reported better-than-expected first-quarter revenue and profit, and flagged the potential for its drugs pipeline amid numerous positive trial findings an...

LONDON BRIEFING: AstraZeneca, Lloyds, GSK post first-quarter growth

(Alliance News) - AstraZeneca, Lloyds Banking Group and GSK report higher earnings in the first quarter.

AstraZeneca Q1 revenues grow, reiterates FY26 constant currency guidance

(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that it had delivered solid revenue growth and a series of positive late‑stage trial readouts in the first quarter, reinforcing confide...

US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvals

* Program aims to reduce trial delays, cut years off ​drug approval timelines

IN BRIEF: AstraZeneca COPD drug Breztri gets US FDA okay for Asthma

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Breztri Aerosphere is approved by the US Food & Drug Administration as a maintenance treatment for asthma in patients 12 years and old...

AstraZeneca's asthma maintenance treatment receives US FDA approval

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it asthma maintenance treatment Breztri Aerosphere had received approval from the US Food and Drug Administration for adults and adolescen...

WINNERS & LOSERS: Energy stocks up, Ceres Power extends rally

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.

AstraZeneca says lupus treatment gets US FDA approval

(Alliance News) - AstraZeneca PLC on Monday said its self-administered lupus treatment has been approved in the US.

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling

(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, while Harworth Group receives planning consent for...

AstraZeneca's Saphnelo Pen gets green light from US FDA

(Sharecast News) - Drugmaker AstraZeneca said on Monday that its systemic lupus erythematosus treatment Saphnelo (anifrolumab) hsd received US Food and Drug Administration approval for self‑admi...

LONDON MARKET CLOSE: Blue chips close lower amid US-Iran stalemate

(Alliance News) - The FTSE 100 ended the week on the back foot as the crisis in the Middle East remained deadlocked.

Supreme Court lawyers leave law firm Paul Weiss for Davis Polk

April 23 (Reuters) - Two veteran U.S. ​Supreme Court lawyers ⁠are leaving law firm Paul Weiss ​for rival Davis Polk, another challenge for the firm after its longtime chairman Brad Karp in February ​r...

Europe risks falling further behind in medicine race, warns Roche CEO

* Roche, Sanofi plan Europe drug launches despite hurdles

IN BRIEF: Arm's Haas to leave AstraZeneca board amid new SoftBank role

AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Rene Haas will step down as a non-executive director on Thursday next week, the end of April, due to his increased executive duties...

UK earnings, trading statements calendar - next 7 days